These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
159 related items for PubMed ID: 12952933
1. GPI-anchored uPAR requires Endo180 for rapid directional sensing during chemotaxis. Sturge J, Wienke D, East L, Jones GE, Isacke CM. J Cell Biol; 2003 Sep 01; 162(5):789-94. PubMed ID: 12952933 [Abstract] [Full Text] [Related]
2. Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression. Kogianni G, Walker MM, Waxman J, Sturge J. Eur J Cancer; 2009 Mar 01; 45(4):685-93. PubMed ID: 19112015 [Abstract] [Full Text] [Related]
3. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase. Vines DJ, Lee SW, Dichek DA, Ellis V. J Pept Sci; 2000 Sep 01; 6(9):432-9. PubMed ID: 11016879 [Abstract] [Full Text] [Related]
4. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator. Mahanivong C, Yu J, Huang S. Mol Carcinog; 2007 Mar 01; 46(3):165-75. PubMed ID: 17186542 [Abstract] [Full Text] [Related]
5. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling. Behrendt N. Biol Chem; 2004 Feb 01; 385(2):103-36. PubMed ID: 15101555 [Abstract] [Full Text] [Related]
6. Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2. Tran H, Maurer F, Nagamine Y. Mol Cell Biol; 2003 Oct 01; 23(20):7177-88. PubMed ID: 14517288 [Abstract] [Full Text] [Related]
7. Urokinase-type plasminogen activator negatively regulates α-smooth muscle actin expression via Endo180 and the uPA receptor in corneal fibroblasts. Sugioka K, Nishida T, Kodama-Takahashi A, Murakami J, Mano F, Okada K, Fukuda M, Kusaka S. Am J Physiol Cell Physiol; 2022 Jul 01; 323(1):C104-C115. PubMed ID: 35649252 [Abstract] [Full Text] [Related]
8. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. EMBO J; 1996 Apr 01; 15(7):1572-82. PubMed ID: 8612581 [Abstract] [Full Text] [Related]
9. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. Høyer-Hansen G, Pessara U, Holm A, Pass J, Weidle U, Danø K, Behrendt N. Biochem J; 2001 Sep 15; 358(Pt 3):673-9. PubMed ID: 11535128 [Abstract] [Full Text] [Related]
10. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA. Kunigal S, Gondi CS, Gujrati M, Lakka SS, Dinh DH, Olivero WC, Rao JS. Int J Oncol; 2006 Dec 15; 29(6):1349-57. PubMed ID: 17088972 [Abstract] [Full Text] [Related]
11. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Plesner T, Behrendt N, Ploug M. Stem Cells; 1997 Dec 15; 15(6):398-408. PubMed ID: 9402652 [Abstract] [Full Text] [Related]
12. Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180. Mousavi SA, Sato M, Sporstøl M, Smedsrød B, Berg T, Kojima N, Senoo H. Biochem J; 2005 Apr 01; 387(Pt 1):39-46. PubMed ID: 15506989 [Abstract] [Full Text] [Related]
13. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Yin S, Lockett J, Meng Y, Biliran H, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S. Cancer Res; 2006 Apr 15; 66(8):4173-81. PubMed ID: 16618739 [Abstract] [Full Text] [Related]
14. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. Fazioli F, Resnati M, Sidenius N, Higashimoto Y, Appella E, Blasi F. EMBO J; 1997 Dec 15; 16(24):7279-86. PubMed ID: 9405357 [Abstract] [Full Text] [Related]
16. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH, Rao JS. Oncogene; 2003 Jan 23; 22(3):392-400. PubMed ID: 12545160 [Abstract] [Full Text] [Related]
17. The urokinase receptor is required for human monocyte chemotaxis in vitro. Gyetko MR, Todd RF, Wilkinson CC, Sitrin RG. J Clin Invest; 1994 Apr 23; 93(4):1380-7. PubMed ID: 8163642 [Abstract] [Full Text] [Related]
18. Monomer dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies. Caiolfa VR, Zamai M, Malengo G, Andolfo A, Madsen CD, Sutin J, Digman MA, Gratton E, Blasi F, Sidenius N. J Cell Biol; 2007 Dec 03; 179(5):1067-82. PubMed ID: 18056417 [Abstract] [Full Text] [Related]
19. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Gutova M, Najbauer J, Frank RT, Kendall SE, Gevorgyan A, Metz MZ, Guevorkian M, Edmiston M, Zhao D, Glackin CA, Kim SU, Aboody KS. Stem Cells; 2008 Jun 03; 26(6):1406-13. PubMed ID: 18403751 [Abstract] [Full Text] [Related]
20. Mitogenic signaling of urokinase receptor-deficient kidney fibroblasts: actions of an alternative urokinase receptor and LDL receptor-related protein. Zhang G, Cai X, López-Guisa JM, Collins SJ, Eddy AA. J Am Soc Nephrol; 2004 Aug 03; 15(8):2090-102. PubMed ID: 15284295 [Abstract] [Full Text] [Related] Page: [Next] [New Search]